While there is no definitive cure for axoplasmic flow stasis, certain therapeutic strategies aim to improve axonal transport. These include the use of neuroprotective agents, antioxidants, and drugs that enhance microtubule stability. Ongoing research is also focused on developing gene therapies that could potentially correct the underlying genetic defects causing the transport issues.
